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A B S T R A C T
Uncontrolled host immunological reactions directed against tissue-trapped eggs precipitate a potentially lethal,
pathological cascade responsible for schistosomiasis. Blocking schistosome egg production, therefore, presents a
strategy for simultaneously reducing immunopathology as well as limiting disease transmission in endemic or
emerging areas. We recently demonstrated that the ribonucleoside analogue 5-azacytidine (5-AzaC) inhibited
Schistosoma mansoni oviposition, egg maturation and ovarian development. While these anti-fecundity eﬀects
were associated with a loss of DNA methylation, other molecular processes aﬀected by 5-AzaC were not ex-
amined at the time. By comparing the transcriptomes of 5-AzaC-treated females to controls, we provide evidence
that this ribonucleoside analogue also modulates other crucial aspects of schistosome egg-laying biology. For
example, S. mansoni gene products associated with amino acid-, carbohydrate-, fatty acid-, nucleotide- and
tricarboxylic acid (TCA)- homeostasis are all dysregulated in 5-AzaC treated females. To validate the metabolic
pathway most signiﬁcantly aﬀected by 5-AzaC, amino acid metabolism, nascent protein synthesis was subse-
quently quantiﬁed in adult schistosomes. Here, 5-AzaC inhibited this process by 68%±16.7% (SEM) in male-
and 81%±4.8% (SEM) in female-schistosomes. Furthermore, the transcriptome data indicated that adult female
stem cells were also aﬀected by 5-AzaC. For instance, 40% of transcripts associated with proliferating schisto-
some cells were signiﬁcantly down-regulated by 5-AzaC. This ﬁnding correlated with a considerable reduction
(95%) in the number of 5-ethynyl-2′-deoxyuridine (EdU) positive cells found in 5-AzaC-treated females. In
addition to protein coding genes, the eﬀect that 5-AzaC had on repetitive element expression was also assessed.
Here, 46 repeats were found diﬀerentially transcribed between 5-AzaC-treated and control females with long
terminal repeat (LTR) and DNA transposon classes being amongst the most signiﬁcant. This study demonstrates
that the anti-fecundity activity of 5-AzaC aﬀects more than just DNA methylation in schistosome parasites.
Further characterisation of these processes may reveal novel targets for schistosomiasis control.
1. Introduction
Schistosoma mansoni is one of eight species of blood ﬂuke parasite
responsible for the neglected tropical disease (NTD) schistosomiasis
(Standley et al., 2012). Mostly restricted to sub-Saharan Africa, the
Middle East and South America, S. mansoni contributes to chronic
human pathology and suﬀering in hundreds of millions of people an-
nually. In S. mansoni (as well as all other schistosome species),
development is complex and involves free-living stages (snail infective
miracidia and human infective cercariae), snail residing forms (asexu-
ally reproductive sporocysts giving rise to cercariae) and human
dwelling varieties (tissue-migrating schistosomula and sexually re-
productive adults). Within the mammalian vascular system, a dioecious
state is reached where female schistosomes (paired with males) lay
hundreds of eggs every day. These eggs migrate across endothelial
barriers into the intestinal lumen and are released together with faeces
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into a freshwater environment. Upon contact with freshwater, mir-
acidia hatch and actively start seeking a snail host to enable con-
tinuation of the lifecycle. However, oviposition also leads to the de-
velopment of pathological lesions (Warren, 1978), where blood ﬂow
away from the site of oviposition (superior mesenteric veins) carries
eggs into hepatic tissues. Here, the host‘s immune response to parasite
eggs trapped in liver sinusoids results in the development of ﬁbrotic
granulomas, portal-systemic shunts, portal vein and pulmonary hy-
pertension, abdominal ascites, oesophageal varices and haematemesis
(reviewed in (Hoﬀmann et al., 2002)). In severe cases, hepatospleno-
megaly can also develop as a result of hepatic and splenic vein pres-
sures, reticuloendothelial hyperplasia and hepatic inﬂammation due to
circumoval granulomas. Clearly, strategies that inhibit or signiﬁcantly
decrease schistosome fecundity would simultaneously reduce egg-in-
duced immunopathology as well as decrease schistosomiasis transmis-
sion.
Due in large part to transcriptome, proteome, glycome and meta-
bolome analyses, new information directly relevant to sexual matura-
tion, oviposition and egg development have been recently obtained
(Fitzpatrick and Hoﬀmann, 2006; Cass et al., 2007; Hokke et al., 2007;
Fitzpatrick et al., 2009; Wu et al., 2009; Ferreira et al., 2014; Pearce
and Huang, 2015; Smit et al., 2015; Lu et al., 2016, 2017; Sotillo et al.,
2017). Together with anti-schistosome drug discovery eﬀorts, which
have identiﬁed compounds that negatively aﬀect schistosome oviposi-
tion (e.g. (Fitzpatrick et al., 2007; Morel et al., 2014; Edwards et al.,
2015; Blohm et al., 2016)), these ‘poly-omics’- related investigations
have highlighted genetic targets and molecular pathways underpinning
crucial events in schistosome reproduction and fecundity. It is now
clear that epigenetic processes also participate in schistosome pheno-
typic plasticity, egg production and other aspects of the dioecious state
(Geyer and Hoﬀmann, 2012; Carneiro et al., 2014; Cosseau et al., 2016;
Picard et al., 2016). While clearly detectable, the signiﬁcance of cyto-
sine methylation (5mC) on schistosome developmental processes,
particularly in the adult, has been recently debated (Geyer et al., 2011;
Raddatz et al., 2013). Studying how cytidine nucleoside analogues,
with known inhibitory activity against DNA methyltransferases
(DNMTs), aﬀect other aspects of schistosome biology may lead to a
more complete picture of the developmentally-important role of this
particular epigenetic modiﬁcation (5mC).
Two well-known cytidine nucleoside analogues are 5-azacytidine
(5-AzaC, a ribonucleoside) and decitabine (DAC, a deoxyribonucleo-
side). Originally described as cytostatic agents (Sorm et al., 1964), both
5-AzaC and DAC are currently used to treat myelodysplastic syndrome
(MDS) and acute myeloid leukemia (AML) (Saba, 2007; Cataldo et al.,
2009). Due to its chemical characteristics, DAC only incorporates into
newly replicated DNA where it covalently traps DNMTs, eﬀectively
inhibiting this enzyme and its DNA methyltransferase activity (re-
viewed in (Stresemann and Lyko, 2008)). However, in addition to its
DNA methyltransferase inhibitory action (Taylor and Jones, 1982), 5-
AzaC is additionally known to impede RNA methylation (Lu and
Randerath, 1980), decrease protein synthesis (Reichman and Penman,
1973) suppress cholesterol and lipid metabolism (Poirier et al., 2014)
and de-repress retroviral expression leading to innate immune response
induction (Strick et al., 2016). These pleiotropic activities are likely
related to 5-AzaC‘s incorporation into both RNA and DNA pools, which
eﬀectively inhibits both DNA- and RNA-methyltransferase function.
In schistosomes, we have previously shown that 5-AzaC, but not
DAC, signiﬁcantly inhibits female speciﬁc biological processes in-
cluding egg production, egg maturation and normal ovarian develop-
ment (Geyer et al., 2011). While co-cultivation in high concentrations
of 5-AzaC did not lead to schistosome death, these drug-associated
phenotypes were directly linked to loss of detectable DNA methylation.
However, at the time of this previous study, no additional information
was obtained to explain how this ribonucleoside aﬀected other aspects
of schistosome biology. Here, we continue our 5-AzaC studies and de-
monstrate that this epigenetic drug (epi-drug) also signiﬁcantly alters
adult female transcription, translation and stem cell activities. There-
fore, in addition to DNA hypomethylation, we postulate that 5-AzaC‘s
negative eﬀect on schistosome oviposition is multi-faceted and aﬀects
core molecular processes (transcription and translation) fundamental to
parasite biology and dioecy. These 5-AzaC aﬀected molecular processes
are unlikely to be parasite selective, thus precluding the further an-
thelmintic development of this ribonucleoside analog. However, the
downstream pathways aﬀected and the phenotypes modulated by 5-
AzaC, as identiﬁed in this study, could represent starting points for new
chemotherapeutic strategies capable of blocking immunopathology and
schistosomiasis transmission.
2. Materials and methods
2.1. Ethics statement
All procedures performed on mice adhered to the United Kingdom
Home Oﬃce Animals (Scientiﬁc Procedures) Act of 1986 (project li-
cense PPL 40/3700) as well as the European Union Animals Directive
2010/63/EU and were approved by Aberystwyth University‘s (AU)
Animal Welfare and Ethical Review Body (AWERB).
2.2. Parasite material
A Puerto Rican strain (NMRI) of Schistosoma mansoni was used
throughout the study and passaged between Mus musculus
(HsdOla:MF1) and Biomphalaria glabrata (NMRI albino and pigmented
hybrid (Geyer et al., 2017)) hosts. Cercariae were shed from both B.
glabrata strains by exposure to light in an artiﬁcially heated room
(26 °C) for 1 h and used to percutaneously infect M. musculus (200
cercariae/mouse) (Smithers and Terry, 1965). Adult schistosomes were
obtained from M. musculus at 7 wk post-infection and used for in vitro 5-
azacytidine (5-AzaC; Sigma-Aldrich, UK) co-cultures, transcriptome
analysis, metabolic labelling experiments and stem cell quantiﬁcation
assays.
2.3. Cultivation of adult schistosome pairs for RNA-Seq analysis
Adult male and female schistosome pairs were cultivated in the
presence (or absence) of 5-AzaC according to the methodology de-
scribed in Geyer et al. (2011). Brieﬂy, adult worm pairs were placed
into 35mm petri-dishes (Thermo Fisher, UK) containing DMEM (Sigma,
UK) supplemented with 10% (v/v) FCS (Thermo Fisher, UK), 2 mM L-
glutamine (Sigma, UK) and 100mg/ml penicillin/streptomycin
(Thermo Fisher, UK). To three replicates (30 schistosome pairs/re-
plicate), 5-AzaC (491 μM in DMEM; ﬁnal concentration) was subse-
quently added. An additional three replicates (30 pairs/replicate),
lacking 5-AzaC, were included as controls. All six schistosome cultures
were incubated at 37 °C for 48 h in a humidiﬁed atmosphere containing
5% CO2. After 48 h, egg counts were recorded and schistosome worms
were subsequently sex-separated and stored in RNAlater (Thermo
Fisher, UK) at−80 °C. Worm viability (5 worm pairs/1 ml media in 48
well tissue culture plates; n= 3) was assessed at 7 days post culture
initiation (5-AzaC and control treated worms) by WormAssay quanti-
ﬁcation (Marcellino et al., 2012).
2.4. RNA isolation, RNA-Seq library preparation and illumina sequencing
Total RNA was isolated using TRI Reagent (Sigma) and the Direct-
zol RNA Mini-Prep Kit (Zymo) according to manufacturer‘s protocol.
One μg of total RNA was used per sample for library construction ac-
cording to the Illumina TruSeq mRNA Library Preparation Kit protocol.
Libraries were quantiﬁed using Qubit ﬂuorescence spectrophotometry
and pooled at equimolar ratios for sequencing in one lane on an
HiSeq2500 platform (2× 101bp format). Reads were demultiplexed,
converted to FASTQ format using the bcl2fastq script and assessed for
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quality control (Andrews, 2010). Raw read ﬁles are deposited in the
NCBI Sequence Read Archive (SRA) under accession number
SRP130864.
2.5. RNA-seq read processing, genome mapping and ﬁltering
Analysis of diﬀerentially expressed genes (DEGs) was performed as
a two-step process. Firstly, Tophat v 2.0.14 was used to perform read
mapping against S. mansoni genome version v 5.2 with default settings
and the genome annotation downloaded from WormBase ParaSite
(Howe et al., 2016, 2017). Secondly, transcript assembly was per-
formed using Cuﬄinks v 2.2.1 to produce a normalised count matrix
(genes.count.tables) consisting of 16,234 assembled transcripts, of
which 9949 could be mapped to 10,820 unique Smp identiﬁers (with
some transcripts mapping to multiple Smps). Sample replicate quality
was assessed by clustering of pairwise Euclidean distances and visua-
lised in a heatmap with treatment (i.e. control or 5-AzaC) as the vari-
able of interest. The biological replicates were, thereafter, combined
and diﬀerential expression analysis performed using the DESeq2
package (Anders and Huber, 2010) at an FDR of 0.05 (using Benjamini-
Hochberg adjustment). Here, 4115 diﬀerentially expressed transcripts
mapping to 4036 unique Smp gene identiﬁers were identiﬁed at a log2
fold change > ±1. Due to splice variants, 21 of these 4036 Smps were
found in both down and up regulated lists of transcripts, giving a total
of 4057 diﬀerently expressed Smps. Finally, 5102 transcripts were
identiﬁed by DESeq2 as having non-signiﬁcant diﬀerential expression.
All analysis steps were performed with default settings.
2.6. Functional enrichment analyses
To investigate functional diﬀerences between the 5-AzaC and con-
trol samples, the g:GHOSt function (moderate ﬁltering) within the
g:Proﬁler webtool was used for the gene ontology (GO) enrichment of
DEGs (Reimand et al., 2016). For the identiﬁcation of pathways asso-
ciated with each set of genes, S. mansoni pathway data were down-
loaded from BioCyc (Caspi et al., 2016) and, thereafter, visualised using
the Neo4j graphical database (Webber, 2012). The BioCyc data consist
of a series of ﬂat ﬁles, from which data on genes, proteins, reactions,
pathways and compounds were extracted. These were then stored as
nodes in a Neo4j graph, with the relationships between them re-
presented as edges. The edges included 1074 enzyme reactions (linking
reaction and protein nodes) with the proteins encoded by genes and the
pathway hierarchy. The transcriptome expression data, stored as log2
fold change, for each gene, were loaded onto this graph as another set
of nodes with edges created to link the data to the respective gene node.
Utilising the cypher language that is part of the Neo4j system, the
network was searched for reactions and the metabolic pathways to
which the enzymes belonged were subsequently deﬁned: 137 and 34
diﬀerentially expressed enzymes were identiﬁed with minimum log2
fold changes of at least± 0 and ± 1, respectively. In the set of 137
enzymes, there were 94 unique Smp gene identiﬁers (some enzymes
were found in multiple pathways); similarly, there were 23 unique
Smps in the set of 34 enzymes. The enzyme network with a log2 fold
change > ±1 was subsequently converted into a Venn diagram for
visualisation purposes. To illustrate an overview of the genome loca-
tions and diﬀerential expression levels of the 4057 Smps (4115 tran-
scripts) in the ﬁltered (log2 fold change > ±1) RNA-Seq dataset, a
Circos plot (Krzywinski et al., 2009) was generated using the S. mansoni
genome v 5.2. Further characterisation of DEGs was performed by ex-
tracting KEGG BRITE (Kanehisa, 2016) functional hierarchical in-
formation for each mapped Smp ID (genome v5.2). Over-representation
analysis was carried out on diﬀerentially expressed Smps identiﬁed by
DESeq2. Signiﬁcantly over-represented pathways (p< 0.05) were
identiﬁed and plotted using clusterProﬁler (Yu et al., 2012) in R. Fi-
nally, a heatmap was used to visualise transcripts that were sig-
niﬁcantly diﬀerentially expressed (adjusted p-value < 0.05) as a
response to 5-AzaC. Transcripts were ranked based on increasing values
of their log2 fold change. The number of stem cell associated transcripts
(Collins et al., 2013) found in these DEGs were then displayed on this
heatmap.
2.7. Signiﬁcantly diﬀerentially expressed repeats
The diﬀerential expression of repeats was performed using
RepEnrich (Criscione et al., 2014). This software handles the technical
diﬃculties that arise when mapping reads to repetitive locations in the
genome (reads deriving from repeats rarely map to unique genome
locations). Following the recommended protocol, we ﬁrst mapped the
reads uniquely to the genome using bowtie (with the –m 1 option),
before calling the RepEnrich.py script with an existing annotation of
repeats in bedﬁle format (Lepesant et al., 2012) to obtain the counts for
each repeat subfamily in each of the samples. Subsequently, the three
control and three 5-AzaC treated samples were assembled into a
2814×6 matrix, where the rows correspond to the 2814 repeat sub-
families and the columns correspond to the 6 samples (3 control vs. 3
treatment samples). The repeat subfamily counts in each control and
treatment sample were normalised to account for sequencing depth. Of
the 2814 repeat subfamilies, those with 0 counts in treatment or control
making a log fold-change impossible to calculate were excluded from
further consideration (726 repeat subfamilies in total). All analyses
were carried out in R.
To identify interesting candidate repeat subfamilies for further
analysis, we used a ﬁltering approach consisting of two steps. First, we
analysed the normalised data with Welch's t-test sequentially to derive a
p-value for the null hypothesis of no diﬀerential expression between
control and treatment samples. At this step, no adjustments for multiple
testing were applied. For each repeat subfamily i, we also calculated its
log fold change (LFCi) as follows:
⎜ ⎟= ⎛
⎝
⎞
⎠
LFC m
m
logi c
t
2
where mc is the mean normalised value of the control samples of the
repeat subfamily i, and mt is the mean normalised value of the treat-
ment samples of the repeat i. Given the problems with interpretation of
data with “small fold change, small variance” and “large fold change,
large variance”, we combined the p-value and the LFCi into a single
ranking score as follows (Xiao et al., 2014):
= − × LFCscore log (p value)i i10
Here, a large negative or positive score indicates that the corre-
sponding repeat subfamily is overexpressed in the treatment or control
samples, respectively. To assess the signiﬁcance of the ranking scores
for the remaining 2088 repeat subfamilies, we used a random permu-
tation test as the second step in the ﬁltering process, which addresses
the problem of multiple testing. Brieﬂy, we randomly permuted the
normalised counts per column 10,000 times and then re-calculated the
resulting scores for each repeat subfamily i. The distribution of the
permutation scores reﬂects the empirical distribution of the score under
the null hypothesis of no association between the counts in the samples
and treatment. Then, for each repeat subfamily, we checked how many
permutation scores are more extreme than the unpermutated score. The
fraction of these scores is the permutation p-value for scorei. We in-
cluded only those repeat subfamilies for which the random permutation
testing yielded a signiﬁcant permutation p-value (< 0.05).
2.8. Metabolic labelling of adult schistosomes and solubilisation of proteins
Adult schistosomes were sex-separated and transferred into 48-well
tissue culture plates at a density of 20 worms per well. Wells contained
1ml of DMEM minus Met (methionine) with and without 5-AzaC
(491 μM). Control wells for each gender, containing DMEM plus Met
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(200 μM ﬁnal concentration), were also included. The parasites were
incubated at 37 °C in 5% CO2 for 4 h, to allow depletion of methionine
reserves of parasites cultured in DMEM minus Met. The labelled me-
thionine analogue Click-iT AHA (L-azidohomoalanine, 20mM in
DMSO) (Life Technologies) was then added to DMEM – Met cultures to
give a ﬁnal concentration of 200 μM. After 24 h, a 70% media exchange
was performed. After 48hr, worms were removed from culture and
washed 3 × in 1 X PBS to eliminate all residual media components.
Worm samples were subsequently suspended in 50 μl lysis buﬀer
(50 mM Tris-HCl + protease inhibitors (cOmplete, mini, EDTA-free
tablets, Roche), pH 8.0) and solubilised using a Qiagen Tissue Lyser LT
and 7 mm stainless steel beads at 50 Hz. Solubilisation was performed
for a total of 3 min and included 4 × 30 s bursts with a 30 s incubation
on ice between cycles. Samples were then placed in a sonicating water
bath for 3 × 30 s (30 s incubation on ice between cycles) to shear the
DNA. Samples were centrifuged at 18,000 × g, 4 °C for 20min to pellet
cell debris, haemozoin (Truscott et al., 2013) and insoluble protein
aggregates. The supernatant was removed and processed for detection
of metabolic label.
2.9. Detection of metabolic label, SDS-PAGE, western blotting and
quantiﬁcation of nascent protein synthesis
The Click-iT detection reaction was performed on whole protein
samples (50 μl) using Biotin Alkyne (Life Technologies, UK) and the
Click-iT Protein Reaction Buﬀer Kit (Life Technologies, UK) according
to the manufacturer‘s instruction. After the detection reaction, each
protein sample was precipitated by adding 600 μl methanol, 150 μl
chloroform and then 400 μl ultrapure water in that order; brief vor-
texing was implemented after each addition. Samples were then cen-
trifuged at 13, 000–18, 000× g at RT for 5min before carefully re-
moving and discarding the upper aqueous solution. A further 450 μl
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Fig. 1. The anti-fecundity action of 5-AzaC
modulates adult female transcriptomes. A) 5-
AzaC signiﬁcantly inhibits S. mansoni egg
production. Thirty-ﬁve adult worm pairs were
cultured either in the presence or absence of
491 μM 5-AzaC. Each culture condition was re-
plicated (n=4) and eggs were collected from
each culture well after 48 h and counted using a
sedgewick rafter. Error bars represent the stan-
dard error of the mean (SEM) and a two-tailed t-
test was performed. * corresponds to p < 0.05.
B) 5-AzaC does not aﬀect adult schistosome
viability. Five worm pairs were cultivated in the
presence (n=3) or absence (n= 3) of 491 μM 5-
AzaC for 7 days. Quantiﬁcation of worm move-
ment (see video in Supplementary Fig. 1) was
performed using WormAssay (Marcellino et al.,
2012). C) Data quality visualisation of RNA-
Seq dataset. The heat map illustrates the Eu-
clidean distance measurements amongst RNA-
Seq replicates calculated from the variance sta-
bilising transformation of the count data using
the DESeq2 package and provides an overview of
similarities/dissimilarities amongst biological
replicates (n=3 for each treatment). Colour
shades indicate level of similarity between li-
braries. D) Clustering of biological replicates
assessed by principal component analysis
(PCA). A PCA was computed using the DESeq2
package in R. Both treatments are represented by
three biological replicates (n= 3), which are
separated by their ﬁrst two principal compo-
nents (percentages of total variation accounted
for by the PCs are show in parentheses). The
control samples are represented by circles and
the 5-AzaC samples by triangles respectively.
(For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the
Web version of this article.)
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methanol was added to the samples, which were again mixed by brief
vortexing before repeat centrifuging at 13, 000–18, 000× g to pellet
the precipitated protein. The supernatant was discarded and the me-
thanol wash (450 μl) was repeated twice more. Finally, all methanol
was removed and the protein samples were dried by vacuum cen-
trifugation and resolubilised in 80 μl SDS-PAGE sample buﬀer (8M
urea, 2% CHAPS (3-3-cholamidopropyl-dimethylammonio-1-propane-
sulphonate), 33mM DTT (dithiothreitol), bromophenol blue).
Protein samples were separated by 1 dimensional SDS-PAGE (pre-
cast 4–12% acrylamide gradient gels, Life Technologies, UK). For male
worms, 5.0 μg of protein sample was loaded per lane and for female
samples, 2.5 μg was used. Gels were electrophoresed according to the
manufacturer‘s instructions and were either Colloidal coomassie stained
(Majek et al., 2013) or subjected to western blot analysis (Hoﬀmann
and Strand, 1997) using 1: 1000 diluted streptavidin-horseradish per-
oxidase (HRP) polymer (ultrasensitive, Sigma-Aldrich, UK) as the pri-
mary antibody and visualised using enhanced chemiluminescence (ECL
Plus, GE Healthcare).
ImageJ was used for quantitative analysis of nascent protein
synthesis using three separate western blot images/treatment. The total
pixel intensity (derived from ﬂuorescence produced by streptavidin-
HRP labelling of biotin tagged proteins) was measured individually for
male and female protein extracts in ImageJ. Lanes were manually an-
notated for each sample and the total pixel intensity was measured
within this region. The pixel intensity measured for male and female
negative controls that contained no AHA (DMEM plus Met only) were
used as a measure of background. These were subtracted from the
associated total pixel intensity values for AHA and AHA+5-AzaC ex-
tracts. The average (+/− standard error) percent AHA incorporation
in 5-AzaC treated male and female schistosomes (normalised to AHA
treated worms only) was subsequently calculated.
2.10. Quantiﬁcation of stem cell populations in adult worms
In vitro 5′-ethynyl-2′-deoxyuridine (EdU) labelling was performed as
previously described (Collins et al., 2013). Brieﬂy, 5-AzaC treated
(491 μM) or control adult females were cultured for 48 h then pulsed
with 10 μM EdU and cultured for a subsequent 24 h. After 72 h, female
schistosomes were ﬁxed, stained and prepared for laser scanning con-
focal microscopy (LSCM) imaging as previously described (Collins
et al., 2013). Anterior regions were imaged and used to determine the
relative number of EdU-labelled nuclei found in 5-AzaC treated worms
compared to those found in control groups. For this quantiﬁcation,
LSCM images were acquired using a Leica TCS SP5II confocal micro-
scope using the 40X lens (NA 1.25), accruing a total of 60 sections for
each Z-stack. For each Z-stack, the ﬂuorescent intensity of the DAPI and
EdU channels (405 nm and 488 nm respectively) were used to calculate
the total volume (μm3) occupied by each ﬂuorophore using the Surface
tool in Imaris v 8.2 (Bitplane). The percentage of EdU positive nuclei
was calculated by dividing the volume of the EdU channel by the vo-
lume of the DAPI channel. To investigate signiﬁcant diﬀerences be-
tween the treatments, a student‘s t-test was performed.
3. Results and discussion
The ribonucleoside analogue 5-AzaC is a known inhibitor of DNA
methyltransferase activity and, thus, has been used to treat epigenetic
disorders associated with DNA methylation dysregulation such as
myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
(Saba, 2007; Cataldo et al., 2009). We have recently demonstrated that
this epi-drug can demethylate the genome in adult schistosomes and
can signiﬁcantly inhibit the production and maturation of in vitro laid
eggs (Geyer et al., 2011). In this study, we used RNA-Seq as a hy-
pothesis generating tool to identify transcripts/pathways/features dif-
ferentially modulated in adult S. mansoni females exposed to this ri-
bonucleoside analogue (Fig. 1). This is because it is known that 5-AzaC
can also aﬀect other cellular processes, in addition to or because of DNA
hypomethylation (Flotho et al., 2009; Hollenbach et al., 2010).
Similar to our previous studies (Geyer et al., 2011), we used a high
concentration (491 μM) of 5-AzaC to maximally elicit the egg laying
defect in in vitro cultivated adult schistosome pairs (Fig. 1A). Here, a
70% reduction in egg output was observed in schistosome pairs (n=35
pairs) treated with 5-AzaC for 48 h when compared to controls. Also
consistent with our previous viability quantiﬁcation (Geyer et al.,
2011), this 5-AzaC mediated anti-fecundity eﬀect was not due to
parasite death as both drug treated and control worm pairs remained
equally active throughout 7 days of culture, retained gut peristalsis (as
indicated by haemozoin movement) and maintained adherence to the
tissue culture wells (Fig. 1B and the video in Supplementary Fig. 1).
Supplementary video related to this article can be found at http://
dx.doi.org/10.1016/j.ijpddr.2018.03.006
It is currently unclear why 5-AzaC (491 μM) remains nontoxic to
adult schistosomes when dose-dependent cytotoxicity has been ob-
served in mammalian cell culture systems (e.g. (Hollenbach et al.,
2010)). However, the protozoan parasite Entamoeba histolytica, another
DNA methyltransferase 2 (DNMT2) only organism (Fisher et al., 2004),
also is not aﬀected by high concentrations of 5-AzaC (23 μM) during
extended co-cultures (up to 7 days) (Ali et al., 2007). Perhaps due to
nucleoside auxotrophy (Levy and Read, 1975a; b), schistosomes (and
other parasites like E. histolytica (McGugan et al., 2007)) carefully
regulate the uptake and transport of these types of (modiﬁed) biomo-
lecules from external environments, which limits their toxic accumu-
lation. Alternatively, high concentrations of 5-AzaC are required to
Table 1
Gene Ontology (GO) analysis of diﬀerentially expressed genes (DEGs).
Down-regulated in 5-AzaC
Biological Process No. of genes associated
to functional term
p-value
nicotinamide nucleotide metabolic
process
18 5.39E-3
ATP metabolic process 30 2.20E-5
carbohydrate metabolic process 47 2.53E-4
carbohydrate derivative metabolic
process
94 2.06E-6
oxidation-reduction process 77 2.01E-5
pyridine nucleotide metabolic process 18 5.39E-3
pyruvate metabolic process 13 8.11E-3
generation of precursor metabolites
and energy
34 6.52E-3
ion transport 92 2.82E-3
transmembrane transport 91 9.63E-4
purine ribonucleoside
monophosphate metabolic
process
33 1.11E-5
Up-regulated in 5-AzaC
Biological Process No. of genes associated
to functional term
p-value
regulation of gene expression 153 8.65E-4
RNA metabolic process 288 1.68E-14
peptidyl-lysine modiﬁcation 21 1.83E-2
cell projection assembly 28 3.99E-4
cellular component organization or
biogenesis
249 1.72E-6
methylation 28 2.23E-3
mRNA export from nucleus 14 4.57E-2
Gene ontology analysis (Biological Process sub ontology) of DEGs between 5-
AzaC-treated and control females using the g:GOSt tool in gProﬁler and mod-
erate hierarchical ﬁltering (Reimand et al., 2016). The number of genes asso-
ciated to each functional term as well as the enrichment p-value for each func-
tional category is shown. Enriched Cellular Component and Molecular Function
gene ontology categories can also be found in Supplementary Fig. 4.
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aﬀect multi-cellular invertebrates during in vitro culture
(Vandegehuchte et al., 2010; Geyer et al., 2017), which clearly is not
necessary for a mammalian cell monolayer. Nevertheless, the co-culti-
vation conditions (5-AzaC concentration and duration) established here
enabled the detailed analysis of transcriptomes derived from viable
drug treated (n= 3 replicates) and control (n= 3 replicates) female
schistosomes.
Assessment of biological reproducibility between RNA-Seq re-
plicates demonstrated a strong relationship. Here, performing either
Euclidean distance evaluation (Fig. 1C) or principal component analysis
(PCA) (Fig. 1D) of diﬀerential expression values, clear clustering
amongst the replicates was observed. Indeed, PCA assessment showed
that almost all variation in experimental outputs (94%) could be ex-
plained by 5-AzaC treatment (i.e. biological variability was minimal
amongst replicates). Amongst the 4115 diﬀerentially expressed tran-
scripts (mapping to 4036 unique Smps) identiﬁed in the study, a total of
2109 transcripts (corresponding to 2079 Smps) were signiﬁcantly
down-regulated by 5-AzaC whereas 2006 transcripts (corresponding to
1978 Smps) were signiﬁcantly up-regulated in adult females
(Supplementary Fig. 2). These DEGs were subsequently subjected to
functional enrichment and pathway information analyses, which
involved classiﬁcation of Smps using descriptors obtained from Gene
Ontology (GO), BioCyc and KEGG.
In female schistosomes, GO analysis (using g:Proﬁler (Reimand
et al., 2016)) revealed eleven Biological Process (BP) categories sig-
niﬁcantly down-regulated by 5-AzaC treatment in comparison to seven
BP categories signiﬁcantly up-regulated (Table 1; Supplementary Fig. 3
also contains details related to Molecular Function and Cellular Com-
ponent GO categories). Amongst the Smps contained within the BP
categories down-regulated by 5-AzaC, many were associated with me-
tabolism of carbohydrates, purines, pyrimidines, ATP and precursors.
Conversely, 5-AzaC led to the up-regulation of Smps associated with
RNA metabolism and methylation (amongst others). While diﬃcult to
directly compare to previous studies examining the eﬀect of 5-AzaC on
other eukaryote cell transcriptomes (Ali et al., 2007; Hollenbach et al.,
2010; Qiu et al., 2010), our results suggest that 5-AzaC dysregulates a
wide-range of metabolic pathways in female schistosomes. To explore
this observation further, the statistically signiﬁcant DEGs were next
analysed for metabolic pathway enrichment using BioCyc (Caspi et al.,
2016) and KEGG (Kanehisa, 2016) (Fig. 2).
Consistent with the GO analysis, of the 1074 enzyme reactions in-
cluded in the BioCyc metabolomics model for S. mansoni, 23 Smps
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Fig. 2. 5-AzaC aﬀects transcripts in-
volved in metabolic processes. A)
Venn diagrams of diﬀerentially ex-
pressed enzymes participating in
metabolic pathways were produced
using data from BioCyc (Caspi et al.,
2016) and the Neo4j graph database.
Smps found more abundantly expressed
in 5-AzaC treated females are marked
with a ‘+’. B) Scatter plot demon-
strating signiﬁcantly over-re-
presented (p< 0.05) KEGG func-
tional hierarchies by diﬀerentially
abundant KEGG orthologs (KOs) be-
tween 5-AzaC-treated and control
females for each dataset. Circle size
represents KO counts within that
pathway while red colouration re-
presents lower p values and, therefore,
higher signiﬁcance. Gene ratio on the x-
axis represents the proportion of genes
represented in the pathway to the total
number of DEGs. (For interpretation of
the references to colour in this ﬁgure
legend, the reader is referred to the
Web version of this article.)
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(coding for enzymes and participating in 34 reaction pathways) had a
log2 fold-change > ±1 and were associated with macromolecule
metabolism (amino acids, carbohydrates, fatty acids, lipids, nucleo-
tides/nucleosides and hormones). Interestingly, most (21/23; 91%) of
these enzymes were down-regulated by 5-AzaC treatment (Fig. 2A and
Supplementary Fig. 4). As well as presenting a vital energy source, these
enzymatically produced biomolecules provide important metabolic in-
termediates for biosynthesis in the parasite and their crucial function in
female fecundity has been highlighted in several previous studies (e.g.
(Bueding, 1970; Meyer et al., 1970; Schiller et al., 1975; Pearce and
Huang, 2015)). Amongst the BioCyc pathways identiﬁed, amino acid
metabolism contained the greatest number of entries (6 Smps). Inter-
estingly, KEGG analysis also identiﬁed amino acid metabolism as the
most statistically signiﬁcant category aﬀected by 5-AzaC in adult fe-
males (Fig. 2B and Supplementary Fig. 5).
Hollenbach et al. have previously reported a 5-AzaC-mediated in-
hibition on nascent protein synthesis in both acute myeloid leukemia
KG-1a and THP-1 human cell lines (Hollenbach et al., 2010). Our
transcriptome results suggested that this ribonucleoside analogue could
be exerting a similar activity in female worms. Therefore, we next in-
vestigated whether 5-AzaC mediated dysregulation in transcripts asso-
ciated with amino acid metabolism correlated to an impact on de novo
protein synthesis in adult worms (Fig. 3). As previously shown for
Schistosoma japonicum (Kawanaka and Sugiyama, 1992), the rate of
amino acid incorporation in adult S. mansoni females was much higher
than males in our experiments (compare the WB signal in 5 μg male vs
Fig. 3. Protein synthesis in adult male and female schistosomes is in-
hibited by 5-AzaC. A) 1D gel analysis of nascent protein synthesis in 5-
AzaC treated worms. Male and female worms were incubated with 200 μM
AHA in the presence or absence of 491 μM 5-AzaC for 48 h to measure its eﬀect
on nascent protein synthesis. Protein extracts were prepared and treated with
biotin-alkyne; equal quantities (male samples 5 μg, female samples 2.5 μg) were
analysed by SDS-PAGE (4–12% gradient gel) before coomassie blue staining
(right), or blotting and probing with streptavidin-HRP (left). Worms were also
incubated in 200 μM methionine (Met) and subsequently processed and ana-
lysed the same way as a measure of non-speciﬁc labelling by streptavidin-HRP.
B) Quantitative analysis of nascent protein synthesis in adult worms in-
cubated with 491 μM 5-AzaC. ImageJ was used to measure the total pixel
intensities of three separate western blots to estimate nascent protein synthesis
inhibition mediated by 491 μM 5-AzaC. Values represent percentage of AHA
incorporation in 5-AzaC treated worms compared to untreated (AHA only)
controls. Error bars represent the standard error of the normalised % in-
corporation AHA means for each gender. (caption on next page)
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2.5 μg female samples; Fig. 3A). This gender diﬀerence in nascent
protein synthesis is due to the increased metabolic demands required by
female schistosomes (regardless of species) for egg production
(Lawrence, 1973). Despite these baseline diﬀerences in amino acid in-
corporation, we found that 5-AzaC dramatically inhibited this process
in both sexes during a 24 h period. Speciﬁcally, 5-AzaC led to a 68%
and 81% inhibition in de novo protein synthesis in male and female
schistosomes respectively (Fig. 3B). This inhibitory eﬀect is likely
caused by the well-recognised ability of 5-AzaC to incorporate into
newly synthesised RNAs (rRNAs, tRNAs, mRNAs and miRNAs), which
alters the molecular functions of these ribonucleic acids and negatively
aﬀects protein synthesis (Reichman and Penman, 1973; Cihak, 1974;
Cihak et al., 1974; Lu and Randerath, 1980). Under these conditions of
functional RNA pool depletion, schistosome protein synthesis and egg
production is unsustainable.
In addition to stable RNA and protein pools, the critical role of both
germinal- and somatic-stem cells in schistosome development as well as
egg production has been recently highlighted (Wendt and Collins,
2016). Therefore, the egg-laying deﬁciency observed during 5-AzaC/
worm pair co-cultures (Fig. 1A) could also be caused by this drug
modulating (via transcription/translation impairment) stem cell func-
tion in adult female schistosomes. Evidence to support this contention
originates in studies demonstrating the role of 5-AzaC in promoting
stem cell diﬀerentiation (Taylor and Jones, 1979; Chen et al., 2015),
although this is not always observed and remains a highly-debated
subject (Martin-Rendon et al., 2008). Nevertheless, as our previous
studies clearly illustrated that, in addition to egg production inhibition,
ovaries (containing germinal stem cells) were also negatively aﬀected
by 5-AzaC (Geyer et al., 2011), we next investigated whether this epi-
drug modulated the diﬀerential expression of 128 transcripts enriched
in proliferating stem cells (Collins et al., 2013) (Fig. 4; Supplementary
Fig. 6). Here, 51 of these stem cell associated transcripts were down-
regulated in response to 5-AzaC treatment, compared to 4 that were up-
regulated; the expression of the remaining 75 transcripts were un-
changed between treatment conditions (Fig. 4A). While it is possible
that some of these results (i.e. the unchanged transcripts) can be ex-
plained by the gender being examined (here, female worms, whereas
Collins et al. examined male worms (Collins et al., 2013)), our data
clearly indicated that 5-AzaC negatively impacts female stem cell pools.
EdU labelling (24 h pulse) of females treated with 5-AzaC for three days
conﬁrmed this observation and revealed the presence of fewer
proliferating cells (EdU+ nuclei) when compared to controls (Fig. 4B).
When quantiﬁed at the anterior ends of females, 5-AzaC led to a 95%
reduction in the number of proliferating stem cells (Fig. 4C). Further
analyses of spatially-distinct stem cell populations (germinal vs so-
matic) may uncover subtle diﬀerences in 5-AzaC-mediated proliferation
modulation in female (as well as male) schistosomes. However, this
discriminatory analysis was beyond the scope of the current study.
Nevertheless, a highly-aﬀected stem cell pool, likely due to dis-
Fig. 4. Stem cell-associated genes aﬀected by 5-AzaC. A) Heatmap of sig-
niﬁcantly diﬀerentially expressed genes, scaled to proportion with nor-
mally expressed genes. First set (Down) of genes (total of 2109) represents
transcripts that are downregulated in drug-treated vs. control samples, whereas
the second set (Up, total of 2006) are transcripts that demonstrate an upregu-
lation in response to drug treatment. The unchanged category (5,102) re-
presents transcripts which are not signiﬁcantly diﬀerently aﬀected by the drug
(adjusted p-value < 0.05). Solid squares represent the 128 proliferating cells-
enriched transcripts (Collins et al., 2013). Colour reﬂects expression levels
ranging from strongly downregulated genes (dark red square – min. value of
−18.1) to strongly upregulated genes (dark green square – max. value of
+4.7). Transcripts are ordered based on increasing values of their log2 fold
change from top-left to bottom-right and each column contains 100 transcripts.
Red circles outline two alternatively spliced products, corresponding to the
same Smp, found in both downregulated AND upregulated categories. B) 5-
AzaC treatment signiﬁcantly aﬀects neoblast numbers and proliferation.
Representative anterior ends of female schistosomes treated with 491 μM of 5-
AzaC (n= 10) or media controls (n=6) after a total culture period of 3 days.
Bar chart illustrates the percentage of neoblasts present in control (media only)
versus 5-AzaC-treated females. Error bars represent standard error of the mean
and a two-tailed t-test (** corresponds to p < 0.001) was subsequently per-
formed to explore a statistical diﬀerence between the cultures. DAPI= blue;
Green=EdU+ cells. Size bar represents 100 μm. (For interpretation of the re-
ferences to colour in this ﬁgure legend, the reader is referred to the Web version
of this article.)
Fig. 5. Analysis of repetitive elements aﬀected by 5-AzaC. A) Volcano plot
illustrating diﬀerential expression of 2088 repeat subfamilies with counts
in both control and 5-AzaC data sets. Repeat subfamilies with a signiﬁcant
permutation p-value (p < 0.05) are highlighted. Overexpressed repeat sub-
families (9) in the 5-AzaC samples are indicated by green dots, whereas
downregulated repeat subfamilies (37) are marked in red. B) The demethy-
lating agent signiﬁcantly aﬀects speciﬁc repeat categories. Relative abun-
dance of the repeat categories (proportion %) which are underexpressed and
overexpressed in the presence of 5-AzaC are represented. Black bars indicate
the proportion (%) of repeat categories, whereas grey bars demonstrate the
proportion of the represented class across the entire genome. Statistical sig-
niﬁcance was assessed using a two-proportions z test (p=0.011 for DNA and
p=0.003 for LTR) and Holm-Bonferroni for multiple comparison corrections.
Nomenclature for repeat classiﬁcations is identical to that described by
Lepesant et al. (Lepesant et al., 2012) except for nRepeat, which deﬁnes tandom
repeat classes (e.g. ATATn or TGCn). (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to the Web version of this
article.)
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regulated transcription and translation, represents another contributing
factor associated with the egg-laying defect observed in 5-AzaC-treated
schistosomes.
In addition to 5-AzaC‘s recognised role in modulating the tran-
scription of protein coding genes (e.g.(Hollenbach et al., 2010), this
study), this epi-drug has also been shown to aﬀect the expression of
endogenous retroviruses (ERVs) and repetitive elements (REs) in
ovarian cell line (TykNu and Hey) or MDS primary cell (CD34+ pro-
genitors) cultures (Chiappinelli et al., 2015; Tobiasson et al., 2017).
Therefore, dysregulated RE expression in 5-AzaC-treated schistosomes
could also be responsible for the egg laying phenotype observed here as
well as in previous studies (Geyer et al., 2011). Examination of the
transcriptome dataset revealed the diﬀerential expression of 2088 REs
between control and drug treated female samples (Fig. 5 and
Supplementary Fig. 7). Amongst these, only 9 REs (represented as solid
green circles) were signiﬁcantly enriched in the 5-AzaC-treated female
samples compared to 37 REs (represented as solid red circles) sig-
niﬁcantly enriched in the control samples (Fig. 5A). As a large pro-
portion of the S. mansoni genome is occupied by repeats (Berriman
et al., 2009; Lepesant et al., 2012), we identiﬁed the signiﬁcantly en-
riched RE categories by comparing their occurrence in our tran-
scriptome dataset to their occurrence in the genome. By doing so, only
two types of RE in 5-AzaC-treated female schistosomes were identiﬁed
as having statistically signiﬁcant changes in transcription: long terminal
repeats (LTR) are under-expressed (p=0.003) and DNA transposons
are over-expressed (p=0.011) (Fig. 5B). The signiﬁcance of these
ﬁndings is unclear, but as more than 33% of the schistosome RE re-
pertoire is transcriptionally active (Lepesant et al., 2012), our results
indicate that normal schistosome oviposition is somehow associated
with controlled RE expression. How 5-AzaC modulates schistosome RE
expression is also currently unknown, but may be related to DNA de-
methylation (i.e. a cercarial RE was previously found to be methylated
(Geyer et al., 2011)) or some other molecular process that disrupts ri-
bonucleic acid pools (Li et al., 1970), histone modiﬁcations (So et al.,
2011) and protein metabolism (as indicated herein). Nevertheless,
transcriptional control of these RE genomic features is likely critical for
maintaining normal developmental features (including egg-laying)
throughout the schistosome lifecycle.
In this study, we extend our understanding of the anti-fecundity
activity of 5-AzaC on S. mansoni. By disrupting both transcription and
translation, this ribonucleoside analogue aﬀects the downstream pro-
cesses of stem cell biology, RE maintenance and schistosome egg pro-
duction in a broad-acting, pleiotropic manner. In addition to DNA
methylation (Geyer et al., 2011), these core molecular activities are
indispensable for maintaining oviposition in mature schistosome pairs.
Future studies aiming to target any one of these essential activities
(summarised in Supplementary Fig. 8) could direct a more speciﬁc
approach in inhibiting schistosome egg production and, thus, oﬀer a
new strategy for controlling schistosomiasis immunopathology and
transmission.
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